IBM Watson Health to Integrate MedyMatch’s AI Deep Vision
19 March, 2017
IBM Watson Health’s Imaging group will distribute the MedyMatch brain bleed detection application globally through its vendor neutral sales channel
MedyMatch Technology revealed a collaboration with IBM Watson Health, to bring MedyMatch’s AI-based clinical decision support application to imaging experts working in hospitals to help identifying intracranial bleeding, as a result of head trauma and stroke. IBM Watson Health’s Imaging group will distribute the MedyMatch brain bleed detection application globally through its vendor neutral sales channels. To do so, IBM Watson Health and MedyMatch will also develop interoperability between MedyMatch’s application and IBM Watson Health Imaging’s offerings.
MedyMatch utilizes advanced cognitive analytics and artificial intelligence to deliver real-time decision support tools to improve clinical outcomes in acute medical scenarios. It created a new category of AI-driven diagnostic tools based on 3D imaging, the breadth of patient-specific data, and other relevant data,concurrently. MedyMatch has developed imaging artificial intelligence engine leverages deep vision and cognitive analytics to compare billions of data points to immediately identify the most rare, long-tail anomalies invisible to the human eye.
Meeting place of Deep Learning and Big Data
The MedyMatch algorithm uses sophisticated deep learning, machine vision, patient data, and clinical insights to automatically highlight for a physician regions of interest that could indicate the potential presence of cerebral bleeds –and does so without interrupting how a physician works.
“The opportunity to license our deep vision application to IBM Watson Health creates a unique value proposition in healthcare,” said Gene Saragnese, chairman & chief executive officer of MedyMatch. “Engaging closely with IBM allows for a near-zero footprint implementation at a customer location delivering ‘A.I. to the bedside’ where I believe the future of healthcare lies. At MedyMatch, we believe improvements in the interpretation of data will lead to better decisions, better decisions will lead to better outcomes for patients and lower cost for healthcare. This is what drives us forward every day.“
Posted in: News